Company intelligence / Profile preview

Diaverum

Ownership: Private
Employees: ~13500
Development stage: Other

Overview

Diaverum operates over 450 clinics in more than 24 countries, providing life-enhancing renal care to approximately 42,000 patients. The company focuses on delivering high-quality dialysis and related services with strong digital and AI infrastructure. It has published research in leading journals but does not conduct pharmaceutical clinical trials.

Therapeutic areas: Nephrology
Modalities: Non-pharmacological therapy (dialysis)Device (dialysis equipment)Preventive care services
Industry: Non-Academic Healthcare

Partnerships

IWantGreatCare (patient feedback partnership)

Beyond the preview

Go deeper on Diaverum.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diaverum.

Explore the full profile